Trial Profile
BALLOON: Efficacy and Safety - Study by ALTANA on Ciclesonide in Pre-school Asthma Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma; Wheezing
- Focus Registrational; Therapeutic Use
- Acronyms BALLOON
- 04 May 2012 Company (Takeda Global Research and Development Center) added as reported by ClinicalTrials.gov.
- 17 Sep 2011 Secondary endpoint 'Forced-expiratory-volume-in-1-second' has been met.
- 17 Sep 2011 Secondary endpoint 'Forced-expiratory-flow-at-75%-of-forced-vital-capacity' has been met.